ERC Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 6 August 2009
DOI: 10.1677/ERC-09-0043
Copyright © 2009 by the Society for Endocrinology.
This Article
Right arrow Accepted manuscript (PDF)
Right arrow All Versions of this Article:
ERC-09-0043v1
ERC-09-0043v2    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Jardé, T.
Right arrow Articles by Vasson, M.-p.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jardé, T.
Right arrow Articles by Vasson, M.-p.

RESEARCH

Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies

Thierry Jardé, Florence Caldefie-Chézet, Nicolas Goncalves-Mendes, Florence Mishellany, Christa Buechler, Frederique Penault-llorca and Marie-paule Vasson

T Jardé, EA4233, CLARA, CRNH-A, Univ Clermont 1, UFR Pharmacie, Clermont-Ferrand, 63000, France
F Caldefie-Chézet, EA4233, CLARA, CRNH-A, Univ Clermont 1, UFR Pharmacie, Clermont-Ferrand, France
N Goncalves-Mendes, EA4233, CLARA, CRNH-A, Univ Clermont 1, UFR Pharmacie, Clermont-Ferrand, France
F Mishellany, Laboratoire d'Anatomopathologie, Centre Jean-Perrin, Clermont-Ferrand, France
C Buechler, Université de Regensburg, Département de Médecine Interne I, Regensburg, Germany
F Penault-llorca, Laboratoire d'Anatomopathologie, Centre Jean-Perrin, Clermont-Ferrand, France
M Vasson, EA4233, CLARA, CRNH-A, Univ Clermont 1, UFR Pharmacie, Clermont-Ferrand, France

Correspondence: Thierry Jardé, Email: jardethierry{at}yahoo.fr

Abstract

Obesity is a risk factor for breast cancer development. A recent hypothesis suggests that the adipokines adiponectin and leptin are involved in breast cancer development. This prompted us to investigate the role of adiponectin and leptin in mammary carcinogenesis. Adiponectin receptors (AdipoR1 and AdipoR2) and leptin receptor (Ob-Rt, representing all the isoforms of Ob-R) proteins were detected by immunohistochemistry in in situ ductal carcinoma, invasive ductal malignancy, and healthy adjacent tissue. In addition, mRNA expression of adiponectin, AdipoR1, AdipoR2, leptin, Ob-Rt and Ob-Rl (the long isoform of Ob-R) was observed in MCF-7 breast cancer cells. Interestingly, leptin mRNA expression was 34.7-fold higher than adiponectin mRNA expression in the MCF-7 cell line. Moreover, adiponectin (10 microg/ml) tended to decrease the mRNA expression of leptin (-36%) and Ob-Rt (-28%) and significantly decreased Ob-Rl mRNA level (-26%). In contrast, leptin treatment (1 microg/ml) significantly decreased AdipoR1 mRNA (-23%). Adiponectin treatment (10 microg/ml) inhibited the proliferation of MCF-7 cells, whereas leptin (1 microg/ml) stimulated the growth of cancer cells. The proliferation was not affected by simultaneous co-incubation with both adipokines (1 microg/ml). Using microarray analysis, we identified that adiponectin reduces the mRNA levels of genes involved in cell cycle regulation (MAPK3, ATM), apoptosis (BAG1, BAG3, MX1, TP53) and potential diagnosis/prognosis markers (ACADS, CYP19A1, DEGS1, EVL) whereas leptin induced progesterone receptor mRNA expression. In conclusion, the current study indicates an interaction of leptin and adiponectin signaling pathways in MCF-7 cancer cells whose proliferation is stimulated by leptin and suppressed by adiponectin.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the Society for Endocrinology.